NEW YORK (GenomeWeb) – Organism design company Ginkgo Bioworks announced today that it has acquired DNA synthesis firm Gen9.

Through the acquisition, Ginkgo has picked up Gen9's manufacturing platform and suite of proprietary technologies, software, and informatics tools for DNA synthesis and assembly, as well as its intellectual property portfolio of more than 125 patents and patent applications. Ginkgo added that it will also retain Gen9's operations and R&D teams.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.